Advertisement
News
Subscribe to MDT Magazine News

What About Us? The State of Women's Sexual Health in Question

January 6, 2011 6:34 am | by Bio-Medicine.Org | Comments

SADDLE BROOK, N.J., Jan. 6, 2011 /- The FDA's nod to a new testosterone gel for men will expand the options they have to address the problems of sexual dysfunction. "So where does this leave women?" asks Rachel Braun Scherl, president of Semprae Laboratories, Inc. The announcement of the...

TOPICS:

Weight-loss surgery improved female urinary problems but male erection issues got worse

January 6, 2011 5:36 am | by EurekAlert | Comments

(Wiley-Blackwell) Women who underwent gastric band surgery to lose weight reported significant improvements in urinary function and quality of life after the operation. But men undergoing the procedure did not enjoy the same significant urinary function improvements as the women....

TOPICS:

Tomatoes found to contain nutrient which prevents vascular diseases

January 6, 2011 5:35 am | by EurekAlert | Comments

(Wiley-Blackwell) They are the most widely produced fruit in the world and now scientists in Japan have discovered that tomatoes contain a nutrient which could tackle the onset of vascular diseases. The research, published in the journal Molecular Nutrition & Food Research, reveals...

TOPICS:
Advertisement

Pro-Pharmaceuticals pulls in $3M from stock financings

January 6, 2011 5:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Newton biotechnology firm Pro-Pharmaceuticals Inc. has closed a $2.1 million private placement offering, in addition to taking in about $1 million from the exercise of common stock warrants.

Neuroptix nabs $4.6M financing

January 6, 2011 5:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Acton-based Neuroptix Corp. has sold $4.6 million of a planned $9.1 million offering of equity and option or warrant securities, according to a regulatory filing. The company is developing combined optical scanning devices and diagnostic agents for the early detection of Alzheimer's disease.

Echo Therapeutics calls on $5.5M in new funding

January 6, 2011 4:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Echo Therapeutics Inc., a medical technology company making a needle-free monitoring and drug delivery system, has taken in $5.5 million in a set of new financing deals led by its majority shareholder Platinum Montaur Life Sciences LLC.

Cardium to Present at OneMedForum San Francisco 2011 Conference

January 6, 2011 4:36 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Jan. 6, 2011 /- Cardium Therapeutics (NYSE Amex: CXM ) today announced today that it is scheduled to present at the OneMedForum Finance Conference for Emerging Healthcare and Life Sciences Companies on Tuesday, January 11, 2011 at 3:00 p.m. (PT) at the Sir Francis Drake Hotel...

TOPICS:

Solos Endoscopy, Inc. Trends toward Strong Continued Growth in 2011

January 6, 2011 4:35 am | by Bio-Medicine.Org | Comments

BOSTON, Jan. 6, 2011 /- Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce that the Company looks towards continued growth in 2011 through new product development, new product sales and the completion of the requirements for its ISO 13485 quality management system (QMS)...

TOPICS:
Advertisement

CVS Caremark Study Finds Medication Adherence Leads to Lower Health Care Costs, Even After Accounting for Increased Prescription Drug Spending

January 6, 2011 4:34 am | by Bio-Medicine.Org | Comments

WOONSOCKET, R.I., Jan. 6, 2011 /- A new CVS Caremark study analyzing annual pharmacy and medical costs over a three-year period for patients with one or more of four chronic diseases concludes that patients who take medications as doctors direct may save the health care system as much as...

TOPICS:

Esperion Therapeutics Initiates Phase 2 Clinical Study for ETC-1002

January 6, 2011 4:34 am | by Bio-Medicine.Org | Comments

PLYMOUTH, Mich., Jan. 6, 2011 /- Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that it has initiated a Phase 2 clinical study for ETC-1002, the company's...

TOPICS:

Amarin Prices Public Offering of American Depositary Shares

January 6, 2011 4:34 am | by Bio-Medicine.Org | Comments

MYSTIC, Conn. and DUBLIN, Jan. 6, 2011 /- Amarin Corporation plc (Nasdaq: AMRN ) (the "Company"), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced the pricing of an underwritten public offering of 12,000,000 American Depositary Shares...

TOPICS:

The Center for Business Intelligence (CBI) Announces Virtual Conference on Imaging for Drug Development

January 6, 2011 4:33 am | by Bio-Medicine.Org | Comments

WOBURN, Mass., Jan. 6, 2011 /- The Center for Business Intelligence (CBI) is pleased to announce Preclinical and Clinical Imaging for Drug Development being held February 23, 2011 from 9:30 am - 6:00 pm EST. CBI provides a unique opportunity to bring together a diverse collection of...

TOPICS:

Former FDA Commissioner Joins Bexion Pharmaceuticals Board

January 6, 2011 4:32 am | by Bio-Medicine.Org | Comments

COVINGTON, Ky., Jan. 6, 2011 /- Bexion Pharmaceuticals, LLC announced today that it has added Lester Crawford, D.V.M., and Ph.D. to its Board of Directors. Dr. Crawford has had a distinguished career in the public and private sectors as well as academia. Over ten years of his career were...

TOPICS:

OnePartner selects MobileMD for Health Information Exchange

January 6, 2011 3:36 am | by Bio-Medicine.Org | Comments

DUFFIELD, Va. and WARMINSTER, Pa., Jan. 6, 2011 /- OnePartner, LLC selects MobileMD, Inc. for Health Information Exchange (HIE) component of innovative, cost effective, and rapidly deployed Electronic Health Record (EHR) solution. Leveraging popular cloud computing techniques designed...

TOPICS:

Echo Therapeutics Receives Funding and Commitment of Approximately $5.5 Million

January 6, 2011 3:36 am | by Bio-Medicine.Org | Comments

FRANKLIN, Mass., Jan. 6, 2011 /- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading